Anebulo Pharmaceuticals segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Analizza lo storico degli utili di Anebulo Pharmaceuticals utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
ANEB | Anebulo Pharmaceuticals | -$0.08 | -$0.12 | — | — | $0.00 | — | — | — | 11/12/2025 | |
ANEB | Anebulo Pharmaceuticals | -$0.05 | -$0.05 | -$0.05 | 0.00% | $0.00 | — | $0.00 | — | 09/29/2025 | |
ANEB | Anebulo Pharmaceuticals | -$0.06 | -$0.05 | -$0.04 | 20.00% | $0.00 | — | $0.00 | — | 05/13/2025 | |
ANEB | Anebulo Pharmaceuticals | -$0.11 | -$0.08 | -$0.09 | -12.50% | $0.00 | — | $0.00 | — | 02/14/2025 | |
ANEB | Anebulo Pharmaceuticals | -$0.10 | — | -$0.08 | — | $0.00 | — | $0.00 | — | 11/13/2024 | |
ANEB | Anebulo Pharmaceuticals | -$0.10 | — | -$0.05 | — | $0.00 | — | $0.00 | — | 09/25/2024 | |
ANEB | Anebulo Pharmaceuticals | -$0.11 | -$0.12 | -$0.06 | 50.00% | $0.00 | — | $0.00 | — | 05/15/2024 | |
ANEB | Anebulo Pharmaceuticals | -$0.15 | -$0.10 | -$0.11 | -10.00% | $0.00 | $0.00 | $0.00 | — | 02/13/2024 | |
ANEB | Anebulo Pharmaceuticals | -$0.11 | -$0.12 | -$0.10 | 16.67% | $0.00 | — | $0.00 | — | 11/14/2023 | |
ANEB | Anebulo Pharmaceuticals | -$0.10 | -$0.12 | -$0.10 | 16.67% | $0.00 | — | $0.00 | — | 09/20/2023 | |
ANEB | Anebulo Pharmaceuticals | -$0.08 | -$0.16 | -$0.11 | 31.25% | $0.00 | — | $0.00 | — | 05/11/2023 | |
ANEB | Anebulo Pharmaceuticals | -$0.05 | -$0.11 | -$0.15 | -36.36% | $0.00 | — | $0.00 | — | 02/10/2023 | |
ANEB | Anebulo Pharmaceuticals | -$0.07 | -$0.10 | -$0.11 | -10.00% | $0.00 | — | $0.00 | — | 11/10/2022 | |
ANEB | Anebulo Pharmaceuticals | -$0.13 | — | -$0.10 | — | $0.00 | — | $0.00 | — | 09/09/2022 | |
ANEB | Anebulo Pharmaceuticals | -$0.69 | — | -$0.08 | — | $0.00 | — | $0.00 | — | 05/11/2022 | |
ANEB | Anebulo Pharmaceuticals | -$0.03 | — | -$0.05 | — | $0.00 | — | $0.00 | — | 02/11/2022 | |
ANEB | Anebulo Pharmaceuticals | -$0.02 | — | -$0.07 | — | $0.00 | — | $0.00 | — | 11/12/2021 | |
ANEB | Anebulo Pharmaceuticals | -$0.01 | -$0.03 | -$0.13 | -333.33% | $0.00 | — | $0.00 | — | 09/22/2021 | |
ANEB | Anebulo Pharmaceuticals | — | — | -$0.69 | — | — | — | $0.00 | — | 06/21/2021 |
Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
---|---|---|---|---|
Q4 | 2025-09-29 | $-0.05 | $-0.05 | 0.00 % |
Q3 | 2025-05-13 | $-0.04 | $-0.05 | 20.0 % |
Q2 | 2025-02-14 | $-0.09 | $-0.08 | -12.5 % |
Q3 | 2024-05-15 | $-0.06 | $-0.12 | 50.0 % |
Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
---|---|---|---|---|
Si prevede che Anebulo Pharmaceuticals (ANEB) fornisca risultati il novembre 12, 2025. Gli ultimi risultati sono stati pubblicati il settembre 29, 2025 per il Q4.
L'EPS effettivo era $-0.05, che centrato la stima di $-0.05.
Le entrate effettive sono state $0K, che centrato la stima di $0K.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.